glp-1 novo nordisk asks FDA to prevent compounders from making knockoffs Blockbuster GLP-1 Diabetes and Weight

Originally developed and FDA-approved to improve blood sugar management in adults with type 2 diabetes, semaglutide works by mimicking a natural hormone in your body

Theyll also create a personalized plan and help you with your dosing and titration schedule

For example, pharmacists were seeing Saxenda, Wegovy, and Zepbound being prescribed for patients who did not have a body mass index (BMI) of 30 kg/m2 or a BMI of 27 kg/m2 with at least one weight associated comorbidity

The SURMOUNT-1 trial tested the ability of tirzepatide to produce weight loss in people with obesity who do not have diabetes

Each batch undergoes independent testing to verify quality, purity, and consistency across production

Gendron MC, Schrantz N, Metivier D, Kroemer G, Maciorowska Z, Sureau F et al